2
Clinical Trials associated with FMT_XBI302Safety and Tolerability of Xbiome Gut Microbial Capsule XBI-302 in Healthy Volunteers
This is a two-part, randomized, double-blind, placebo-controlled, single center study to investigate the safety and tolerability of XBI-302 administered orally in healthy volunteers. The hypothesis of this study is that XBI-302 is safe and well tolerated with the proposed dosing regimens.
Evaluating the Efficacy and Safety of FMT Capsules XBI-302 Combined With Nivolumab in the Treatment of Anti-PD-1/L1 Resistant Gastric Cancer
This study is a single-arm, single center study. The purpose of this study is to evaluate the efficacy and safety of FMT capsules XBI-302 combined with Nivolumab in the treatment of anti-PD-1/L1 resistant gastric cancer.
100 Clinical Results associated with FMT_XBI302
100 Translational Medicine associated with FMT_XBI302
100 Patents (Medical) associated with FMT_XBI302
100 Deals associated with FMT_XBI302